Conference Presentations

  • Keynote : Address

    Presentation

    Mark McClellan, MD, PhD
    Robert J. Margolis Professor of Business, Medicine, and Policy, and Director , Margolis Center for Health Policy at Duke University,
  • Presentation 1 : Current Value Frameworks – What’s New?

    Presentation

    Josh Seidman, PhD, MHS
    PhD, MHS, Senior Vice President, Avalere Health,
  • Presentation 1 : Current Value Frameworks – What’s New?

    Presentation

    Patrick Gleason, PharmD
    PharmD, Senior Director of Health Outcomes, Prime Therapeutics,
  • Presentation 1 : Current Value Frameworks – What’s New?

    Presentation

    Rick Chapman, PhD, MS
    PhD, MS, Director of Health Economics, Institute for Clinical and Economic Review (ICER),
  • Presentation 1 : Current Value Frameworks – What’s New?
  • Presentation 2 : Novel Approaches to Value Assessment, Within the Cost-Effectiveness Framework

    Presentation

    Jeroen Jansen, PhD
    PhD, Lead Scientific Advisor of the Open Source Value Project (OSVP), Innovation and Value Initiative,
  • Presentation 2 : Novel Approaches to Value Assessment, Within the Cost-Effectiveness Framework

    Presentation

    Susan Griffin, PhD
    PhD, Senior Research Fellow, University of York,
  • Presentation 2 : Novel Approaches to Value Assessment, Within the Cost-Effectiveness Framework

    Presentation

    Lou Garrison, PhD
    PhD, Professor Emeritus, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute (School of Pharmacy), University of Washington,
  • Presentation 2 : Novel Approaches to Value Assessment, Within the Cost-Effectiveness Framework

    Presentation

    Nancy J. Devlin, PhD
    PhD, Director of Research, Office of Health Economics,
  • Presentation 2 : Novel Approaches to Value Assessment, Within the Cost-Effectiveness Framework
  • Presentation 3 : Novel Approaches to Value Assessment, Beyond Cost-Effectiveness Framework

    Presentation

    Charles Phelps, PhD
    PhD, University Professor and Provost Emeritus, University of Rochester, Gualala, CA, USA,
  • Presentation 3 : Novel Approaches to Value Assessment, Beyond Cost-Effectiveness Framework

    Presentation

    Reed Johnson, PhD
    PhD, Professor of Medicine, Duke Clinical Research Institute, Duke University,
  • Presentation 3 : Novel Approaches to Value Assessment, Beyond Cost-Effectiveness Framework

    Presentation

    Robert Dubois, MD, PhD
    MD, PhD, Chief Science Officer & Executive Vice President, National Pharmaceutical Council (NPC),
  • Presentation 3 : Novel Approaches to Value Assessment, Beyond Cost-Effectiveness Framework

    Presentation

    J. Jaime Caro, MDCM
    MDCM, Chief Scientist, Evidera,
  • Presentation 3 : Novel Approaches to Value Assessment, Beyond Cost-Effectiveness Framework
  • Presentation 4 : Specific Value Assessment Considerations

    Presentation

    Adrian Towse, MA, MPhil
    MA, MPhil, Director, Office of Health Economics,
  • Presentation 4 : Specific Value Assessment Considerations

    Presentation

    Patricia Danzon, PhD
    PhD, Celia Moh Professor Emeritus, Health Care Management Department, The Wharton School, University of Pennsylvania,
  • Presentation 4 : Specific Value Assessment Considerations